Journal of Cystic Fibrosis

Scope & Guideline

Advancing knowledge in cystic fibrosis management.

Introduction

Delve into the academic richness of Journal of Cystic Fibrosis with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1569-1993
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2002 to 2024
AbbreviationJ CYST FIBROS / J. Cyst. Fibros
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The Journal of Cystic Fibrosis aims to advance the understanding and treatment of cystic fibrosis (CF) through comprehensive research. It encompasses a wide range of topics related to the disease, focusing on innovative therapies, clinical management, and the associated health outcomes.
  1. CFTR Modulator Therapy:
    A significant focus on the effectiveness and safety of CFTR modulators, including elexacaftor, tezacaftor, and ivacaftor, in treating various CF genotypes.
  2. Microbiome Research:
    Exploration of the cystic fibrosis microbiome, including its interactions with disease pathology and treatment responses, particularly regarding Pseudomonas aeruginosa and other pathogens.
  3. Quality of Life and Patient-Centered Care:
    Assessment of health-related quality of life and the psychosocial impact of cystic fibrosis on patients and their families, emphasizing the importance of holistic care.
  4. Nutritional Management:
    Research on dietary interventions, nutritional status, and gastrointestinal complications in cystic fibrosis, recognizing the critical role of nutrition in disease management.
  5. Longitudinal Studies and Registries:
    Utilization of registry data and longitudinal studies to understand disease progression, treatment outcomes, and long-term health implications for cystic fibrosis patients.
  6. Clinical Guidelines and Standards of Care:
    Development and dissemination of evidence-based clinical guidelines to improve standard care practices for cystic fibrosis patients across different demographics.
The Journal of Cystic Fibrosis is witnessing a surge in research themes that reflect the evolving landscape of cystic fibrosis treatment and care. These emerging scopes highlight the journal's responsiveness to new challenges and innovations within the field.
  1. Telehealth and Digital Health Innovations:
    An increasing number of studies are focusing on telehealth implementations and digital health tools to improve care delivery and patient engagement, especially in light of the COVID-19 pandemic.
  2. Pharmacogenomics and Personalized Medicine:
    Research into pharmacogenomic approaches is gaining traction, aiming to tailor CF treatments based on individual genetic profiles, thereby enhancing therapeutic efficacy.
  3. Impact of Socioeconomic Factors:
    Emerging themes are addressing the influence of socioeconomic factors on health outcomes in cystic fibrosis, emphasizing the need for equitable access to care and treatment.
  4. Mental Health and Psychosocial Research:
    There is a growing emphasis on mental health outcomes and the psychosocial impact of living with cystic fibrosis, highlighting the importance of addressing emotional well-being in treatment plans.
  5. Longitudinal Outcomes of Novel Therapies:
    Studies focusing on the long-term effectiveness and safety of recently approved therapies, particularly CFTR modulators, are becoming increasingly prevalent.

Declining or Waning

While the Journal of Cystic Fibrosis continues to thrive with emerging topics, some areas of research have seen a decline in focus over recent years. These waning themes may reflect shifts in clinical priorities or advancements in treatment modalities.
  1. Basic Science Research:
    There has been a noticeable decrease in basic science studies focused solely on the pathology of cystic fibrosis, as the field shifts towards applied research and clinical trials.
  2. Traditional Antibiotic Therapies:
    Interest in conventional antibiotic therapies appears to be waning, likely due to the rise of new CFTR modulators and alternative treatment strategies that target the underlying cause of the disease.
  3. Palliative Care Research:
    Although still important, there seems to be less emphasis on palliative care studies compared to previous years, possibly overshadowed by advancements in curative and disease-modifying therapies.
  4. Longitudinal Studies of Older Treatment Regimens:
    Research focusing on the long-term efficacy of older treatment regimens, such as dornase alfa, is becoming less frequent as newer therapies dominate clinical discussions.

Similar Journals

ACTA ONCOLOGICA

Unraveling complexities in cancer care and imaging.
Publisher: Medical Journal Sweden ABISSN: 0284-186XFrequency: 12 issues/year

ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.

SEMINARS IN DIALYSIS

Elevating clinical practices in the realm of dialysis.
Publisher: WILEYISSN: 0894-0959Frequency: 6 issues/year

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

HAEMOPHILIA

Advancing knowledge in hematology and genetics.
Publisher: WILEYISSN: 1351-8216Frequency: 6 issues/year

HAEMOPHILIA is a leading peer-reviewed journal published by Wiley, dedicated to advancing research and clinical practices in the fields of hematology and genetics. With an impressive Impact Factor and recognition within the Q1 category for Genetics (clinical), Hematology, and Medicine (miscellaneous), this journal presents a unique platform for the dissemination of high-quality research from 1995 to the present. Researchers in these dynamic fields will find invaluable insights through original articles, systematic reviews, and clinical trials, all aimed at improving therapeutic strategies and patient outcomes. Although it operates on a subscription basis, HAEMOPHILIA's commitment to excellence is reflected in its Scopus rankings, where it stands in the 74th percentile for hematology and the 71st percentile for clinical genetics. As an essential resource for academics, healthcare professionals, and students, HAEMOPHILIA plays a pivotal role in fostering innovation and collaboration within the global medical community.

Pain Management

Advancing the Future of Pain Relief.
Publisher: FUTURE MEDICINE LTDISSN: 1758-1869Frequency: 12 issues/year

Pain Management, published by Future Medicine Ltd, is a premier journal that serves the fields of anesthesiology, pain medicine, and dentistry. With its ISSN 1758-1869 and E-ISSN 1758-1877, this journal is committed to advancing knowledge and practice through high-quality research articles, clinical studies, and expert reviews. The journal has established itself as a pivotal resource in pain management with a commendable impact factor and recognition in category quartiles, achieving Q2 rankings in Anesthesiology and Pain Medicine, as well as in miscellaneous Medicine and Dentistry categories as of 2023. Researchers and professionals will find a wealth of information in its comprehensive articles, which are essential for staying at the forefront of developments in pain management therapies and techniques. Although access is not open, the journal is recognized for its rigor and significance in shaping the future of pain management practices globally. Join the community of experts engaging in cutting-edge discussions by exploring the impactful research being published in this essential resource.

Journal of Diabetes Investigation

Connecting researchers to elevate diabetes science.
Publisher: WILEYISSN: 2040-1116Frequency: 6 issues/year

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

Gut and Liver

Transforming patient care through innovative research.
Publisher: EDITORIAL OFFICE GUT & LIVERISSN: 1976-2283Frequency: 6 issues/year

Gut and Liver is a prestigious peer-reviewed journal dedicated to advancing the fields of Gastroenterology and Hepatology. Published by the EDITORIAL OFFICE GUT & LIVER in South Korea, this Open Access journal has been disseminating valuable research findings since 2007, making critical knowledge accessible to a global audience. With an impressive 2023 impact factor that places it in Q1 rank in both Gastroenterology (#28/167) and Hepatology (#22/82), it is recognized as a leader in the medical domain. The journal covers diverse topics, including innovative therapeutic strategies, clinical practices, and groundbreaking research in liver diseases and gastrointestinal disorders, thereby playing a vital role in improving patient care and outcomes. Researchers, healthcare professionals, and students can benefit from the journal's wealth of information, designed to foster collaboration and spark new ideas within the scientific community. For further engagement with current research, readers can access issues from 2009 to 2024 and stay updated on the latest advancements in the field.

JCO Oncology Practice

Driving Change in Cancer Care Through Policy and Practice
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2688-1527Frequency: 6 issues/year

JCO Oncology Practice is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, specializing in the intersection of oncology and health policy. Established as a vital resource since 2020, this journal serves as a platform for the dissemination of innovative research, policy analysis, and clinical practice advancements aimed at enhancing cancer care. With its impressive impact factor and recognition in the top quartile (Q1) across multiple categories including Health Policy and Oncology, JCO Oncology Practice ranks #3 in Oncology Nursing and consistently shares cutting-edge insights that drive improvements within the field. The journal is accessible to a broad audience through its open access options, ensuring that vital knowledge reaches practitioners, researchers, and students alike. By prioritizing the latest evidence-based practices and addressing contemporary challenges in cancer treatment, JCO Oncology Practice plays an essential role in shaping the future of oncology practice and policy in the United States and beyond.

JOURNAL OF GASTROINTESTINAL SURGERY

Advancing gastrointestinal surgery through rigorous research.
Publisher: ELSEVIER SCIENCE INCISSN: 1091-255XFrequency: 12 issues/year

JOURNAL OF GASTROINTESTINAL SURGERY, published by Elsevier Science Inc, is a premier academic journal dedicated to advancing the field of gastrointestinal surgery. Since its inception in 1997, this journal has served as a vital resource for researchers, clinicians, and students, providing a platform for the dissemination of high-quality original research, reviews, and innovative surgical techniques. With a solid impact factor and ranked Q1 in Surgery and Q2 in Gastroenterology as of 2023, it boasts an impressive Scopus ranking that highlights its influence in both medical and surgical spheres. Situated in the United States, the journal emphasizes the importance of peer-reviewed research that contributes to improved surgical practices and patient outcomes. Although currently not offering open access, its robust editorial policies ensure rigorous quality control, making it an essential reference for anyone involved in gastrointestinal research and surgery.

RHEUMATOLOGY INTERNATIONAL

Innovating clinical approaches for better patient care.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Practical Radiation Oncology

Connecting Research with Real-World Applications
Publisher: ELSEVIER SCIENCE INCISSN: 1879-8500Frequency: 6 issues/year

Practical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.